Apocrine Carcinoma - Explore the Science & Experts | ideXlab

Scan Science and Technology

Contact Leading Edge Experts & Companies

Apocrine Carcinoma

The Experts below are selected from a list of 1086 Experts worldwide ranked by ideXlab platform

Jorge Soto De Delas – 1st expert on this subject based on the ideXlab platform

  • Apocrine Carcinoma adenopathies and raised tag 72 serum tumor marker
    Dermatologic Surgery, 2004
    Co-Authors: Jorge Santosjuanes, Jose Francisco Bernaldo De Quiros, Cristina Galache Osuna, Maria Teresa Allende, Maria Victoria Folgueras, Jorge Soto De Delas

    Abstract:

    Background. The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.

    Results. We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.

    Conclusion. To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.

  • Apocrine Carcinoma, Adenopathies, and Raised TAG‐72 Serum Tumor Marker
    Dermatologic Surgery, 2004
    Co-Authors: Jorge Santos-juanes, Jose Francisco Bernaldo De Quiros, Cristina Galache Osuna, Maria Teresa Allende, Maria Victoria Folgueras, Jorge Soto De Delas

    Abstract:

    Background. The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.

    Results. We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.

    Conclusion. To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.

Jorge Santosjuanes – 2nd expert on this subject based on the ideXlab platform

  • Apocrine Carcinoma adenopathies and raised tag 72 serum tumor marker
    Dermatologic Surgery, 2004
    Co-Authors: Jorge Santosjuanes, Jose Francisco Bernaldo De Quiros, Cristina Galache Osuna, Maria Teresa Allende, Maria Victoria Folgueras, Jorge Soto De Delas

    Abstract:

    Background. The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.

    Results. We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.

    Conclusion. To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.

Maria Victoria Folgueras – 3rd expert on this subject based on the ideXlab platform

  • Apocrine Carcinoma, adenopathies, and raised TAG-72 serum tumor marker.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020
    Co-Authors: Jorge Santos-juanes, Maria Teresa Allende, Maria Victoria Folgueras, José Francisco Bernaldo De Quirós, Cristina Galache Osuna, José Sánchez Del Río, Jorge Soto De Delás

    Abstract:

    The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.
    We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.
    To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.

  • Apocrine Carcinoma adenopathies and raised tag 72 serum tumor marker
    Dermatologic Surgery, 2004
    Co-Authors: Jorge Santosjuanes, Jose Francisco Bernaldo De Quiros, Cristina Galache Osuna, Maria Teresa Allende, Maria Victoria Folgueras, Jorge Soto De Delas

    Abstract:

    Background. The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.

    Results. We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.

    Conclusion. To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.

  • Apocrine Carcinoma, Adenopathies, and Raised TAG‐72 Serum Tumor Marker
    Dermatologic Surgery, 2004
    Co-Authors: Jorge Santos-juanes, Jose Francisco Bernaldo De Quiros, Cristina Galache Osuna, Maria Teresa Allende, Maria Victoria Folgueras, Jorge Soto De Delas

    Abstract:

    Background. The detection of tumor-associated glycoprotein-72 in the serum of patients with Carcinomas, basically of the colon, has proved to be of great use in the follow-up of these gastrointestinal adenoCarcinomas.

    Results. We report the case of a male patient presenting adenopathies in the right axilla. The histologic study of an adjacent skin tumor enabled the diagnosis of a cutaneous Apocrine Carcinoma. Among the studies made, the increase in the serum antibody CA72.4 can be highlighted. The tumor marker was negative after the extirpation of the skin tumor and the axillary adenopathies.

    Conclusion. To our best knowledge, this is the first case in which a tumor serum marker is associated with a cutaneous Apocrine Carcinoma, a fact that should be confirmed with further patients. Its use in the monitoring of this infrequent skin neoplasia is also noteworthy.